Back to Search
Start Over
Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma
- Authors :
- UU BETA RESEARCH
Poon, Evon
Liang, Tong
Jamin, Yann
Walz, Susanne
Kwok, Colin
Hakkert, Anne
Barker, Karen
Urban, Zuzanna
Thway, Khin
Zeid, Rhamy
Hallsworth, Albert
Box, Gary
Ebus, Marli E
Licciardello, Marco P
Sbirkov, Yordan
Lazaro, Glori
Calton, Elizabeth
Costa, Barbara M
Valenti, Melanie
De Haven Brandon, Alexis
Webber, Hannah
Tardif, Nicolas
Almeida, Gilberto S
Christova, Rossitza
Boysen, Gunther
Richards, Mark W
Barone, Giuseppe
Ford, Anthony
Bayliss, Richard
Clarke, Paul A
De Bono, Johann
Gray, Nathanael S
Blagg, Julian
Robinson, Simon P
Eccles, Suzanne A
Zheleva, Daniella
Bradner, James E
Molenaar, Jan
Vivanco, Igor
Eilers, Martin
Workman, Paul
Lin, Charles Y
Chesler, Louis
UU BETA RESEARCH
Poon, Evon
Liang, Tong
Jamin, Yann
Walz, Susanne
Kwok, Colin
Hakkert, Anne
Barker, Karen
Urban, Zuzanna
Thway, Khin
Zeid, Rhamy
Hallsworth, Albert
Box, Gary
Ebus, Marli E
Licciardello, Marco P
Sbirkov, Yordan
Lazaro, Glori
Calton, Elizabeth
Costa, Barbara M
Valenti, Melanie
De Haven Brandon, Alexis
Webber, Hannah
Tardif, Nicolas
Almeida, Gilberto S
Christova, Rossitza
Boysen, Gunther
Richards, Mark W
Barone, Giuseppe
Ford, Anthony
Bayliss, Richard
Clarke, Paul A
De Bono, Johann
Gray, Nathanael S
Blagg, Julian
Robinson, Simon P
Eccles, Suzanne A
Zheleva, Daniella
Bradner, James E
Molenaar, Jan
Vivanco, Igor
Eilers, Martin
Workman, Paul
Lin, Charles Y
Chesler, Louis
- Publication Year :
- 2020
Details
- Database :
- OAIster
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1379173548
- Document Type :
- Electronic Resource